Category Archives: Stock Market

“How Starbucks Operates Like a Bank While Serving Coffee”

Amidst talk of barista unionizing, supply chain issues and increasing competition, Starbucks maintains its dominance in the coffee world.

“Dogecoin Could Turn Into a Real Currency To Spend Rather Than Hoard”

“…by 2040, there will be no more Bitcoins able to be mined. As a result, this will encourage excessive hoarding of the supply of Bitcoins. This will push up the Bitcoin price, but reduce the actual trading volume of the Bitcoins (i.e., deflating the float available). On the other hand, by allowing five billion Dogecoins per year to increase the supply of Dogecoins for infinity, the supply will grow, but eventually, reach a practical limit. Therefore, we can calculate the inflation rate of the currency over time.”


We Want You!

We’re Buying BNGO

Say we won’t! We started buying in September and the company has released nothing but incredible news since (except for the two secondary offerings) but…

“The company’s cash position is in better shape than its Q4 results indicate. Since the beginning of this year, Bionano has raised around $335 million through two stock offerings. CFO Chris Stewart said that Bionano believes its cash stockpile “significantly de-risks the company, solidifies our financial future, and allows us to focus on the achievement of our long-term vision to disrupt genomics through the global adoption of Saphyr.”

Bionano has a lot to look forward to in the next few quarters. It expects to obtain accreditation for Saphyr-based laboratory-developed tests for acute lymphocytic leukemia (ALL) and facioscapulohumeral muscular dystrophy (FSHD) in some European markets in Q2. The company plans a commercial release of prenatal assays and an expansion of the menu of its pediatric assays in Q3. 

The fourth quarter of 2021 will be an especially busy one. Bionano anticipates the validation of three of its laboratory-developed tests with billing codes. It also expects to have a prototype of its next-generation high-throughput Saphyr system ready. 

If all goes according to plan, Bionano will finish this year with a much larger installed base. The company projects that it will have 150 systems installed by the end of Q4 2021 — a 50% jump from the end of 2020.”

The Recent Pullback in Bionano Genomics Is a Major Buying Opportunity



Vericel (VCEL) Set to Join S&P SmallCap 600

Our knee injury stem cell stock VCEL is being added to the S&P SmallCap 600. The stock price is responding appropriately and is trading at all-time highs as we type this.

“Vericel Corp. (NASD:VCEL) will replace QEP Resources Inc. (NYSE:QEP) in the S&P SmallCap 600 effective prior to the opening of trading on┬áMonday, March 22. S&P 500 constituent Diamondback Energy Inc. (NASD:FANG) has acquired QEP Resources in a transaction that closed today.” read more

“Cathie Wood discusses her investing picks, plus her insight on Reddit, GameStop, Tesla and Bitcoin”

Here is the manager of the best-performing money fund talking about her market positions:

Also here she’s promoting the genomics sector (our largest holding is Bionano Genomics):

XRP On Sale!

The redheaded stepchild of cryptocurrencies (Ripple) is being sued by the SEC. Find out why!